ClinicalTrials.gg
Drug

Romosozumab clinical trials

Also written Evenity and AMG 785.

studies test it
39
open now
9
in phase 3
10
first study started
2006

How each study uses romosozumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the romosozumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Apr 2019 · EVENITY · BLA 761062 (FDA, Drugs@FDA)
European Union
9 Dec 2019 · Evenity · EMEA/H/C/004465 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Romosozumab
35

Brand

Evenity
26

Development codes

AMG 785
18

Studies by the year they started

37 studies that test it; most in 2021 (7); 2 more planned to start later

Studies that test romosozumab, by start year
YearStudies
20061
20071
20093
20102
20124
20133
20141
20171
20181
20201
20217
20233
20242
20253
20264

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
8
Phase 3
10
Phase 4
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 17

Amgen (21) · Tuen Mun Hospital (3) · Memorial Sloan Kettering Cancer Center (2) · Massachusetts General Hospital (2) · Susan L. Greenspan (1) · James J. Peters Veterans Affairs Medical Center (1) · UCB Biopharma SRL (1) · VA Office of Research and Development (1)

Often tested with

Tested in the same studies.

Denosumab (4) · Zoledronic Acid (3)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test romosozumab, phase 3 first.

Studies

Open first, then newest update. How each study uses romosozumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 39

See all 39 studies that test romosozumab →

Given beside what is tested · 3 — romosozumab is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with romosozumab

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call romosozumab · ClinicalTrials.gg INT005797

  • MeSH (NLM) C557282romosozumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3VHF2ZD92JROMOSOZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2123126One source FDA
  • Wikidata Q7363297RomosozumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152246RomosozumabOne source FDA
  • DrugBank DB11866One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.